Inflammation and Heart Disease: How to Reduce Your Risk After 55

by Goldman Labs Team

Key Takeaways

Understanding the connection between inflammation and heart disease after 55 empowers you to take proactive steps that can significantly reduce your cardiovascular risk and improve your long-term health outcomes.

• Chronic inflammation drives heart disease after 55 through "inflamm-aging" - a process where persistent low-grade inflammation damages arteries and accelerates plaque formation in aging cardiovascular systems.

• Regular testing of inflammatory markers is essential - Request high-sensitivity C-reactive protein tests, with levels above 2 mg/L indicating elevated cardiovascular risk requiring intervention.

• Mediterranean diet patterns reduce heart inflammation as effectively as medications, with anti-inflammatory foods like leafy greens, fruits, and whole grains significantly lowering cardiac event risk.

• Exercise provides powerful anti-inflammatory benefits - Aim for 150 minutes weekly of moderate activity to improve blood flow, reduce inflammatory markers, and strengthen cardiovascular health.

• Women face unique post-menopausal risks due to estrogen decline triggering increased inflammation, requiring specialized screening and prevention strategies including early menopause monitoring.

• Medical interventions show proven results - Statins, omega-3 supplements, and emerging therapies like colchicine can reduce cardiovascular events by 15-37% in high-risk patients.

The key to successful heart inflammation management lies in combining lifestyle modifications with appropriate medical monitoring, creating a comprehensive approach that addresses both the biological changes of aging and modifiable risk factors.

Inflammation heart disease over 55 represents a critical health concern. Both low-grade systemic inflammation and aging increase cardiovascular morbidity and mortality on their own2. This phenomenon, known as inflamm-aging, is characterized by chronic, low-grade inflammation that accompanies aging and damages the cardiovascular system by a lot33. Cardiovascular diseases remain a global health challenge, with ischemic heart disease being the main cause of both morbidity and mortality34. Understanding how heart inflammation develops and recognizing the signs of an inflamed heart enables people to take proactive steps toward protection and prevention.

The connection between inflammation and heart disease after 55

Chronic systemic inflammation acts as a fundamental driver of cardiovascular deterioration in people over 55. It creates a cascade of destructive processes within arterial walls. The biological mechanisms that link inflammation to heart disease involve complex interactions between immune cells, oxidative stress and vascular tissue. These interactions intensify with advancing age.

How inflammation damages arteries

Excessive deposition of low-density lipoprotein penetrates vascular endothelial cells and begins the arterial damage process. The LDL undergoes oxidation into oxidized LDL35. This oxidized LDL promotes cytokine release and attracts monocytes to the lesion site. It triggers recruitment of additional inflammatory cells35. Reactive oxygen species overproduction or defective scavenging contributes to stress-induced premature senescence critically and participates in cardiovascular system aging2.

Endothelial dysfunction emerges as a key demonstration during early inflammatory stages35. Abnormal expression of adhesion molecules and chemokines results in inflammatory cell recruitment to lesion sites35. Vascular cell adhesion molecule-1 binds the types of leukocytes found in early atheroma precisely, specifically monocytes and T lymphocytes3. Monocyte chemoattractant protein-1 appears responsible for direct migration of monocytes into the intima at sites of lesion formation3.

Pro-inflammatory cytokines impair endothelial cell barrier function and vasodilator properties. They induce adhesion molecules and chemokines that recruit leucocytes to lesions2. Activated T cells and macrophages release proinflammatory mediators such as IL-1, IL-3, IL-8, IL-18 and TNF-α. These attract circulating inflammatory cells and trigger perpetual local inflammatory response4. Elevated IL-6 levels have been associated with increased risk of future myocardial infarction in apparently healthy men. This supports inflammation's role in early atherogenesis stages4.

Inflamm-aging and cardiovascular risk

A state of chronic sterile low-grade inflammation characterizes older organisms. It participates in the development of frailty, disability and most chronic degenerative diseases, including age-related cardiovascular and cerebrovascular afflictions2. This inflamm-aging promotes catastrophic athero-thrombotic complications. It does so by improving platelet reactivity and predisposing to plaque rupture and erosion2.

The effect of inflamm-aging on age-related cardiovascular disease extends beyond atherosclerosis development. In fact, it interacts with traditional cardiovascular risk factors such as overweight, obesity, hypertension and Type 2 diabetes mellitus. These interactions exacerbate their deleterious cardiovascular effects2. This relationship is reciprocal. Cardiovascular conditions can promote inflammation and propel a vicious cycle that links inflamm-aging to cardiovascular disease development2. Postmenopausal women often exhibit higher levels of inflammatory markers like C-reactive protein and interleukin-6. These are associated with elevated risks of cardiovascular and other age-related conditions5. Understanding inflammation and hormonal changes during menopause provides additional context for cardiovascular risk assessment in women.

The etiology of inflamm-aging involves genetic factors, cellular senescence, immunosenescence and age-related changes in coagulation and gut microbiota4. Cellular senescence suppresses proliferation of genotypically damaged cells while contributing to wound healing. Senescent cells accumulate with age in many tissues4. They promote age-related disease through their senescence-associated secretory phenotype. This alters structure and function of different organs4. This secretory profile consists of soluble molecules including IL-1α, IL-1β, IL-6, chemokines, growth factors and metalloproteinases. These act in paracrine manner and contribute to inflamm-aging systemically4.

The role of plaque formation

Cholesterol crystals and other damage-associated molecular patterns within atherosclerotic lesions co-activate the NLRP3 inflammasome in macrophages. They increase production of active forms of pro-inflammatory cytokines IL-1β and IL-182. The resulting inflammatory environment intervenes in ongoing cellular recruitment. This generates foam cells and fatty streaks that eventually lead to complex plaque development2.

Senescent cells accumulate in advanced atherosclerotic plaques. They are identified through specific markers such as senescence-associated β galactosidase, p16 and tumor suppressor alternative reading frame2. Increased rate of these senescence-positive cells localizes in intimal and medial layers from atherosclerotic arteries compared with age-matched healthy vessels2. Senescent cells produce matrix metalloproteinases at increased rates subsequently. This improves extracellular matrix breakdown and increases remodeling of advanced atherosclerotic plaques2.

Degradation of extracellular matrix makes vascular smooth muscle cell migration from the media easier. It intervenes in arterial compensatory enlargement and weakens the plaque's protective fibrous cap2. Vascular smooth muscle cells sustain DNA damage and telomere shortening under these conditions. This promotes stress-induced premature senescence with loss of proliferative abilities, defective autophagy and induction of apoptosis2. Vulnerable plaques prone to thrombosis possess pathological features. These include thin fibrous caps, large necrotic lipid cores, abundant inflammatory cells and small amounts of smooth muscle cells35. The stability of atherosclerotic plaques is negatively associated with the number of inflammatory cells and necrotic lipid core size. It is positively associated with fibrous cap thickness35.

Biological changes that increase inflammation with age

Diagram illustrating key cellular senescence pathways and their molecular interactions leading to cell cycle arrest.

Multiple biological transformations occur within the aging body. These changes intensify inflammation and escalate inflammation heart disease over 55 risk. They operate at cellular, immune system, and metabolic levels and create interconnected pathways that perpetuate chronic inflammatory states.

Cellular senescence and its effects

Cells enter an irreversible growth arrest after a finite number of divisions. They transition into a senescent state characterized by profound metabolic alterations36. Senescent cells exhibit a distinctive senescence-associated secretory phenotype that secretes interleukin-1, IL-6, IL-8, IL-13, IL-18, and tumor necrosis factor along with its receptors. This causes the inflammaging phenotype36. This secretory profile acts as a paracrine reservoir of pro-inflammatory cytokines, chemokines, growth factors, and proteases37.

The accumulation of damaged macromolecules causes inflammaging. Endogenous host-derived cell debris serves as the source of chronic tissue damage36. Senescent cells remain metabolically active despite cell cycle arrest and influence neighboring cells and tissues through inflammatory factor secretion37. Receptors on natural killer cells, T cells, and monocytes/macrophages recognize certain SASP components. This affects other immune cells which further release more proinflammatory cytokines and aggravate age-related pathology38.

These cells develop immune evasion mechanisms to avoid destruction. Senescent cells express immunosuppressive molecules that include PD-L1 and PD-L2 to ligate PD-1 on T cells, along with tolerogenic MHC class-I variants39. Senescent cells avoid removal and continue accumulating because the immune system becomes dysfunctional with increasing age40. The immune system's reduced capacity to clear these cells perpetuates a vicious cycle that fuels heart inflammation and cardiovascular deterioration.

Immunosenescence explained

Immunosenescence includes organ reorganization and many regulatory processes at the cellular level. This results in decreased immune system function and inadequate responses to infections or vaccines in elderly individuals36. Characteristic changes include thymic involution, hematopoietic stem cell dysfunctions, disrupted naïve/memory ratio in T and B cells, impaired new antigen response, mitochondrial dysfunction, genomic instability, and stress responses36.

Thymic involution impairs the immune system's capacity to react to novel antigens. It reduces thymopoiesis and causes a change toward memory T cells41. Chronic antigenic stress triggers an inflammatory status via progressive activation of macrophages. This results in poor responses to newly encountered antigens and a change toward immunosenescence36. The deterioration of macrophage function contributes to immunosenescence. The capability of macrophages to clear senescent cells from tissues reduces with aging42.

An imbalance between inflammatory and immune reactions during aging reduces efficiency of immune responses. It creates an immunosuppressive microenvironment38. Inflammatory mediators promote myelopoiesis and increase immunosuppressive cells, especially regulatory T cells and M2 macrophages that secrete transforming growth factor-β, ROS, and interleukin-1038. High levels of proinflammatory cytokines damage human B cells and reduce production of protective antibodies38.

Oxidative stress and mitochondrial dysfunction

Reactive oxygen species exhibit a hierarchical effect on cellular health. Mild amounts of ROS propagate lipid peroxidation chains and induce apoptosis and autophagy in oxidatively damaged cells. High levels in cells cause harmful effects during aging and associate tightly with inflammaging and aging-related diseases36. The increase in ROS creates oxidative stress, and proteasome activity decreases. This causes protein oxidative modification and functional decline which are the foundations of inflammaging and cellular senescence36.

Mitochondrial dysfunction often accompanies the senescence phenotype43. Oxidative stress generated by defects in mitochondrial components induces cellular senescence. Mitochondrial deregulation can cause cellular senescence44. Increased ROS production accelerates telomere shortening in cells and triggers cellular senescence onset through sustained DNA damage response44. The rate of telomere shortening relates to cellular oxidative stress levels45.

Cumulative damage to mitochondria and accumulation of mutations in mtDNA caused by ROS deteriorates mitochondrial functions. This happens through alteration in electron transport chain component expression44. ROS-mediated damage in oxidative phosphorylation machinery alters enzymatic activity of mitochondrial respiratory enzymes and reduces mitochondrial membrane potential. ATP production becomes compromised44. Age-related glycolytic metabolism levels decrease and mitochondria energy metabolism becomes abnormal. This impairs T and B cell activation38.

Common conditions that worsen heart inflammation

Illustration depicting inflammation's role and future perspectives in heart failure treatment and research.

Several chronic medical conditions create a perfect storm for inflammation heart disease over 55. Each contributes unique inflammatory pathways that damage cardiovascular structures. These conditions raise baseline inflammation and interact cooperatively to accelerate arterial damage and plaque formation.

Diabetes and insulin resistance

Patients with type 1 and type 2 diabetes face 2-4 fold higher risk of developing heart disease or stroke compared to those without diabetes46. This elevated cardiovascular threat persists even when blood glucose levels remain managed47. Adults with diabetes demonstrate twice the likelihood of experiencing heart disease or stroke47, with cardiovascular causes emerging as leading contributors to mortality among diabetic patients48.

Type 2 diabetes has insulin resistance as a metabolic characteristic, and type 1 diabetes commonly shows this condition as well48. This condition contributes to atherosclerosis development through multiple mechanisms. These include glucose and lipid metabolism disorders, endothelial dysfunction, coagulation abnormalities, and smooth muscle cell dysfunction48. Both hyperglycemia and hyperinsulinemia implicate themselves in cardiovascular disease pathogenesis46.

Diabetes operates as a chronic condition associated with systemic low-grade inflammation. It promotes vascular inflammation by upregulating pro-inflammatory gene expression48. High-sensitivity C-reactive protein serves as a prominent biomarker of systemic inflammation. Its predictive value for cardiovascular events has been verified in coronary artery disease settings of all types48. Chronic low-grade inflammation and production of proinflammatory cytokines have been linked with insulin resistance. These cytokines include tumor necrosis factor α, interleukin-6, IL-8, plasminogen activator inhibitor-1, and monocyte chemoattractant protein-149.

Hypertension and vascular inflammation

More than 80% of patients with type 2 diabetes mellitus develop hypertension, while about 20% of hypertensive patients develop diabetes1. One-third of the adult population has hypertension, and it stands as the leading cause of premature death and loss of disability-adjusted life years7. The combination of these cardiovascular risk factors accounts for much of cardiovascular morbidity and mortality1.

The pathophysiology of cardiovascular disease in patients with hypertension and diabetes involves multiple factors. Recent evidence points toward an important component dependent on a low-grade inflammatory process1. Angiotensin II may be largely responsible for triggering vascular inflammation by inducing oxidative stress. This results in up-regulation of pro-inflammatory transcription factors such as nuclear factor κB1. These factors regulate generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury1.

Inflammatory markers increase in patients with hypertension and metabolic disorders. These include C-reactive protein, chemokines, and adhesion molecules that predict cardiovascular disease development1. Blood pressure increases show linear relationships with inflammatory markers. Systolic blood pressure and pulse pressure associate with intercellular adhesion molecule-1 levels13.

Chronic kidney disease

Patients with chronic kidney disease exhibit markedly elevated cardiovascular risk. 50% of all patients with CKD stage 4 to 5 have cardiovascular disease, and cardiovascular mortality accounts for about 40% to 50% of all deaths in patients with advanced CKD9. Those with CKD face 20 times higher likelihood of dying from cardiovascular disease than kidney failure14.

Chronic kidney disease causes a systemic, chronic proinflammatory state. This contributes to vascular and myocardial remodeling processes that result in atherosclerotic lesions, vascular calcification, vascular senescence, and myocardial fibrosis9. Proinflammatory mediators increase as kidney function declines and exhibit direct effects in the vasculature15.

Autoimmune disorders

Autoimmune diseases associate with increased risk of cardiovascular disease, especially atherosclerotic cardiovascular disease. These include systemic lupus erythematosus and rheumatoid arthritis10. Patients with rheumatoid arthritis have 50% greater risk of atherosclerotic cardiovascular disease, like the cardiovascular risk seen with diabetes10. Atherosclerotic cardiovascular disease risk estimates among those with immune disorders versus healthy controls show considerable elevation: rheumatoid arthritis 1.5-2 fold, psoriatic arthritis 1.5-1.7 fold, vasculitis 2-12 fold, and systemic lupus erythematosus 2-3 fold10.

Each 1-unit increase in the systemic lupus erythematosus disease activity index score conferred 5% increase in atherosclerotic cardiovascular disease risk after adjusting for traditional risk factors10. Black and Hispanic lupus patients experience more severe disease than White patients and demonstrate much higher risks of atherosclerotic cardiovascular events10.

Testing and monitoring your inflammation levels

Detecting elevated inflammation requires specific blood tests that measure various inflammatory markers circulating in the bloodstream. These diagnostic tools enable physicians to assess cardiovascular risk related to heart inflammation and monitor disease progression if you have concerns about inflammation heart disease over 55.

Blood tests you should request

High-sensitivity C-reactive protein stands as the most studied and verified biomarker of systemic inflammation and functions as a strong predictor of cardiovascular risk16. The American College of Cardiology released a scientific statement recommending universal screening of hs-CRP in both primary and secondary prevention populations16. The liver manufactures this protein in response to inflammation, and it tends to rise when inflammatory processes are present8.

Beyond hs-CRP, several markers provide valuable information about inflammatory status. Erythrocyte sedimentation rate measures how fast red blood cells settle to the bottom of a vertical tube of blood. Faster settling means inflammation is present8. Fibrinogen, a blood clotting protein, tends to rise during inflammatory states8. Ferritin reflects iron storage but also raises when inflammation is present8. More sophisticated inflammatory markers include interleukin-6 and interleukin-8, which have shown prognostic meaning for cardiovascular events17.

Understanding your results

CRP levels categorize into three risk tiers: less than 1 mg/L means low risk, 1-3 mg/L represents intermediate risk, and 3 mg/L or greater signals high risk18. An hs-CRP level at or above 2 mg/L is a risk-enhancing factor in current guidelines for cardiovascular risk assessment16. ESR measures 20 mm/hr or less under normal conditions, while values over 100 mm/hr are quite high8. Fibrinogen levels range from 200 to 400 mg/dL under normal conditions8. Ferritin falls between 20 to 200 mcg/L, though ranges vary by laboratory and tend higher in men8.

Keep in mind that these tests cannot distinguish between acute inflammation from conditions like pneumonia or injury and chronic inflammation accompanying conditions like diabetes or obesity8. A value of 0.8-1.0 mg/dL or lower is thought to be a healthy CRP amount19.

How often to get checked

CRP levels remain stable over a period of months or a few years18. This is not a test requiring regular repetition18. You should avoid testing during any kind of infection or acute inflammation, such as a cold or flu, because CRP levels will be very high in these situations18. If you have cardiovascular disease or multiple risk factors, discuss testing frequency with a healthcare provider to allow for personalized monitoring strategies based on your circumstances20.

Evidence-based strategies to lower inflammation

Various anti-inflammatory spices and herbs including turmeric, chili, ginger, garlic, cinnamon, and coriander displayed on a white wooden surface.

Addressing inflammation heart disease over 55 requires a multifaceted approach that combines dietary modifications, physical activity, weight control, targeted supplementation and pharmaceutical interventions when needed.

Anti-inflammatory eating patterns

The Mediterranean diet reduces cardiovascular disease burden through improvements in waist-to-hip ratio, lipids and inflammatory markers. Benefits rival those of aspirin, beta-blockers and ACE-inhibitors21. Better conformity with this dietary pattern produces meaningful reductions in coronary heart disease, ischemic stroke and total cardiovascular disease22. Diets rich in anti-inflammatory foods show fewer cardiac events. These include leafy greens, dark yellow vegetables, fruits and whole grains. Pro-inflammatory foods like red meat, refined carbohydrates and sugary beverages increase heart attack and stroke risk23.

Physical activity guidelines

Regular physical activity reduces inflammation throughout the body24. Exercise improves blood flow, insulin sensitivity, blood pressure and cholesterol levels while decreasing damaging inflammation25. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic exercise each week plus muscle-strengthening activities twice a week26. Walking 30 minutes daily proves effective for most people. Those at higher cardiovascular risk should aim for 45 minutes25.

Weight management to control inflammation

Weight loss produces most important decreases in inflammatory biomarkers that match the amount lost27. Obese study participants who lost weight experienced reductions in both serum amyloid A and C-reactive protein after three months27. Major weight loss appears to reverse most cardiovascular risks linked with obesity28. Understanding inflammation and menopause provides additional context for women managing weight-related heart inflammation.

Supplements and natural approaches

Fish oil supplements containing omega-3 fatty acids demonstrate anti-inflammatory effects6. High-dose prescription omega-3 reduces cardiovascular events in high-risk patients29. Omega-3 and testosterone relationships deserve attention in detailed cardiovascular approaches. Curcumin may decrease inflammation in diabetes, inflamed heart conditions and inflammatory bowel disease6.

Medical therapies and emerging treatments

Colchicine reduced major cardiovascular events by 23% in post-heart attack patients over 22.6 months11. Canakinumab at 150 mg led to a 15% reduction in heart attack, stroke and cardiovascular death11. Statins reduce arterial inflammation, with rosuvastatin 20 mg lowering hsCRP by 37%11.

Special considerations for women after menopause

Illustration highlighting increased cardiovascular disease risk in women during menopause transition.

Women face distinct physiological changes during the menopausal transition that alter inflammation heart disease over 55 risk profiles, requiring specialized preventive approaches.

Hormonal changes and inflammation

Estrogen decline during perimenopause and menopause triggers increased body inflammation due to decreased levels of estradiol, progesterone, and testosterone30. These hormones have receptors on macrophages. Hormone levels drop and these immune cells become pro-inflammatory and damage tissues30. Estrogen provides protective effects by helping control cholesterol levels and reducing fat buildup in arteries while keeping blood vessels healthy31. Fat accumulates in arteries when estrogen levels fall. This causes narrowing and increased coronary heart disease risk31. Postmenopausal women exhibit higher inflammatory marker levels like C-reactive protein and interleukin-630. The connections between inflammation and menopause are essential for cardiovascular protection.

Unique cardiovascular risks

Women with early menopause before age 45 demonstrate 50% higher overall coronary heart disease risk and 11% higher fatal coronary heart disease risk compared to those experiencing menopause at 45 or later12. Depression during menopause transition links to elevated cardiovascular risk. Three or more depression episodes associate with elevated coronary artery calcification by a lot12. Vasomotor symptoms affect approximately 80% of midlife women and may need medical treatment12. The menopause transition associates with marked increases in carotid atherosclerosis and arterial stiffness, with a 7.5% increase in arterial stiffness within one year following the final menstrual period12.

Prevention strategies for women

Women should pursue at least 150 minutes of physical activity weekly to lower heart disease risk32. Regular screenings include cholesterol checks every five years and blood pressure every two years, with BMI assessment at every healthcare visit32. Approaches like omega-3 and testosterone relationships warrant consideration in detailed cardiovascular strategies.

Conclusion

Heart inflammation represents a manageable threat rather than an inevitable consequence of aging. Understanding how inflamm-aging damages cardiovascular structures helps people over 55 take decisive action to protect their hearts. Recognizing common conditions that intensify this process is equally vital.

Regular testing of inflammatory markers provides critical feedback on cardiovascular risk levels. Anti-inflammatory dietary patterns combined with consistent physical activity and strategic weight management produce measurable reductions in inflammatory biomarkers. Proven medical therapies offer most important protection if you need additional support.

The evidence is clear: proactive inflammation management translates into reduced cardiovascular events and improved longevity after 55.

FAQs

Q1. Can exercise help reverse heart failure? Regular physical activity is a powerful tool for managing heart health. Exercise improves blood flow, reduces inflammation throughout the body, enhances insulin sensitivity, and helps control blood pressure and cholesterol levels. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic exercise weekly, combined with muscle-strengthening activities twice per week. While exercise provides significant cardiovascular benefits, individuals with existing heart conditions should consult their healthcare provider before starting any new exercise program.

Q2. How can women reduce their heart disease risk after menopause? Women can take several important steps to protect their hearts after menopause. Regular screenings are essential, including cholesterol checks every five years, blood pressure monitoring every two years, and blood glucose testing every three years. Maintaining at least 150 minutes of physical activity weekly significantly lowers heart disease risk. Following an anti-inflammatory eating pattern rich in leafy greens, fruits, whole grains, and healthy fats while limiting red meat and refined carbohydrates also provides substantial protection during this vulnerable period.

Q3. What dietary approach is most effective for reducing heart inflammation? The Mediterranean diet has proven particularly effective for reducing cardiovascular inflammation and disease burden. This eating pattern emphasizes leafy greens, dark yellow vegetables, fruits, whole grains, fish, and healthy fats while limiting red meat, refined carbohydrates, and sugary beverages. Studies show that better adherence to this diet produces clinically meaningful reductions in coronary heart disease, ischemic stroke, and total cardiovascular disease, with benefits comparable to certain medications.

Q4. Can people with coronary artery disease live a long life? With proper management, many people with coronary artery disease can live long, fulfilling lives. Success depends on controlling inflammation through lifestyle modifications including anti-inflammatory eating patterns, regular physical activity, weight management, and when necessary, appropriate medical therapies. Regular monitoring of inflammatory markers and cardiovascular risk factors allows for timely interventions. Proactive inflammation management translates directly into reduced cardiovascular events and improved longevity, particularly for those over 55.

Q5. What blood tests should I request to monitor heart inflammation? High-sensitivity C-reactive protein (hs-CRP) is the most validated biomarker for assessing cardiovascular inflammation risk. Levels below 1 mg/L indicate low risk, 1-3 mg/L represents intermediate risk, and 3 mg/L or higher signals high risk. Additional useful markers include erythrocyte sedimentation rate (ESR), fibrinogen, and ferritin. Since CRP levels remain generally stable over months, this test doesn't require frequent repetition. However, avoid testing during any infection or acute illness, as CRP levels will be artificially elevated during these times.

References

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your GP or qualified healthcare professional before making changes to your diet, lifestyle or supplementation. Goldman Laboratories products are food supplements and are not intended to diagnose, treat, cure or prevent any disease.

Language